Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1638-1643

  Adams, Linda B ^a   Sinha, Indu ^b   Franzblau, Scott G ^a   Krahenbuhl, James L ^a   Mehta, Reeta T ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER LEVEL; LUNG INFECTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0032798081     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1638     Document Type: Article

References (29)

1. Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246.
2. Adams, L. B., C. M. Mason, J. K. Kolls, D. Scollard, J. L. Krahenbuhl, and S. Nelson. 1995. Exacerbation of acute and chronic murine tuberculosis by administration of a TNF receptor-expressing adenovirus. J. Infect. Dis. 171: 400-405.
3. Agarwal, A., H. Kandpal, H. P. Gupta, N. B. Singh, and C. M. Gupta. 1994. Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice. Antimicrob. Agents Chemother. 38:588-593.
4. Bermudez, L. E. 1994. Use of liposomal preparations to treat mycobacterial infections. Immunobiology 191:578-583.
5. Bermudez, L. E. M., M. Wu, and L. S. Young. 1987. Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. J. Infect. Dis. 156:510-513.
6. Bermudez, L. E. M., A. O. Yau-Young, J. P. Lin, J. Cogger, and L. S. Young. 1990. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome encapsulated aminoglycosides. J. Infect. Dis. 161: 1262-1268.
7. Cynamon, M. H., C. E. Swenson, G. S. Palmer, and R. S. Ginsberg. 1989. Liposome-encapsulated amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 33:1179-1183.
8. Dayan Sandler, E., V. L. Ng, and W. K. Hadley. 1992. Clofazimine crystals in alveolar macrophages from a patient with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 116:541-543.
9. Duzgunes, N., D. R. Ashlekar, D. L. Flasher, N. Ghori, R. J. Jacobs, D. S. Friends, and P. R. Gangadharam. 1991. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposomal encapsulated streptomycin: role of liposome type and duration of treatment. J. Infect. Dis. 164:143-151.
10. Forster, D. J., D. M. Causey, and N. A. Rao. 1992. Bull's eye retinopathy and clofazimine. Ann. Intern. Med. 116:876-877.
11. Gallets, J. C. 1991. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection. Ann. Pharmacother. 25:525-531.
12. Gangadharam, P. R., D. A. Ashtekar, N. Ghori, J. A. Goldstein, R. J. Debs, and N. Duzgunes. 1991. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J. Antimicrob. Chemother. 28: 425-435.
13. Grover, A. A., H. K. Kim, E. H. Wiegeshaus, and D. W. Smith. 1967. Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at - 70°C. J. Bacteriol. 94:832-840.
14. Jacobson, R. R. 1997. Treatment of leprosy, p. 470. In R. C. Hastings (ed.), Leprosy, 2nd ed. Churchill Livingstone, Edinburgh, United Kingdom.
15. Kansal, R. G., R. Gomez-Flores, I. Sinha, and R. T. Mehta. 1997. Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection. Antimicrob. Agents Chemother. 41:17-23.
16. Karlowsky, J. A., and G. G. Zhanel. 1992. Concepts of the use of liposomal antimicrobial agents: applications for aminoglycosides. Clin. Infect. Dis. 15: 654-667.
17. Kesavalu, L., J. A. Goldstein, R. J. Debs, N. Duzgunes, and P. R. J. Gangadharam. 1990. Differential effects of free and liposome-encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. Tuber. Lung Dis. 71:215-218.
18. Le Conte, P., F. LeGallou, G. Potel, L. Struillou, D. Baron, and H. B. Drugeon. 1994. Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob. Agents Chemother. 38:2695-2701.
19. Mehta, R. T. 1989. Liposomes as drug carriers for polyene antibiotics. Adv. Drug Deliv. Rev. 3:283-306.
20. Mehta, R. T. 1996. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Antimicrob. Agents Chemother. 40:1893-1902.
21. Mehta, R. T., A. Keyhani, T. J. McQueen, B. Rosenbaum, K. V. Rolston, and J. J. Tarrand. 1993. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob. Agents Chemother. 37:2584-2587.
22. Mehta, R. T., T. J. McQueen, A. Keyhani, and G. Lopez-Berestein. 1991. Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. J. Infect. Dis. 164:1003-1006.
23. Mehta, R. T., S. Poddar, M. Kalidas, G. Gomez-Flores, and K. Dulski. 1996. Role of macrophages in the candidacidal activity of liposomal amphotericin B. J. Infect. Dis. 175:214-217.
24. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. B. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
25. Sepkowitz, K. A., J. Raffalli, L. Riley, T. E. Kiehn, and D. Armstrong. 1995. Tuberculosis in the AIDS era. Clin. Microbiol. Rev. 8:180-199.
26. Swenson, C. R., M. C. Popescu, and R. S. Ginsberg. 1988. Preparation and use of liposomes in the treatment of microbial infections. Crit. Rev. Microbiol. 15:S1-S31.
27. Takada, M., T. Yuzuhira, K. Katayama, K. Iwamoto, and J. Sunamoto. 1984. Increased lung uptake of liposomes coated with polysaccharides. Biochim. Bioiphys. Acta 802:237-244.
28. Tomioka, H., H. Saito, K. Sato, and T. Yoneyama. 1991. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. Am. Rev. Respir. Dis. 144:575-579.
29. Vladimirsky, M. A., and G. A. Ladigina. 1982. Antibacterial activity of liposome-entrapped streptomycin in mice infected with Mycobacterium tuberculosis. Biomedicine 36:375-377.